カシリビマブ・イムデビマブ (Japanese Wikipedia)
Analysis of information sources in references of the Wikipedia article "カシリビマブ・イムデビマブ" in Japanese language version.
refsWebsite
Global rank
Japanese rank
low place
low place
low place
low place
615th place
1,955th place
49th place
67th place
5,225th place
low place
18th place
107th place
low place
low place
low place
low place
14th place
320th place
406th place
1,806th place
17th place
799th place
1,531st place
103rd place
low place
low place
low place
low place
7th place
63rd place
5th place
19th place
1st place
1st place
low place
low place
archive.today
- “Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81%”. streetinsider.com. 2021年4月12日時点のオリジナルよりアーカイブ。2021年4月12日閲覧。
bbc.com
- Morelle, Rebecca (2020年9月14日). “Antibody treatment to be given to Covid patients”. BBC News Online 2020年9月14日閲覧。
bioprocessintl.com
- Stanton, Dan (2020年9月11日). “Manufacturing shift to Ireland frees up US capacity for Regeneron's COVID antibodies”. BioProcess International
businesswire.com
- “Genentech and Regeneron Collaborate to Significantly Increase Global Supply of REGN-COV2 Investigational Antibody Combination for COVID-19”. Business Wire (2020年8月19日). 2021年6月8日閲覧。
- “Genentech and Regeneron Collaborate to Significantly Increase Global Supply of REGN-COV2 Investigational Antibody Combination for COVID-19” (2020年8月19日). 2021年7月1日閲覧。
cipla.com
clinicaltrials.gov
- “Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19”. ClinicalTrials (2020年9月3日). 2020年9月14日閲覧。
cnbc.com
- “Roche and Regeneron link up on a coronavirus antibody cocktail”. (2020年8月19日) 2020年9月14日閲覧。
dailygazette.com
- Williams, Stephen (2020年10月3日). “Experimental drug given to President made locally”. The Daily Gazette
doi.org
- Baum A, Fulton BO, Wloga E, Copin R, Pascal KE, Russo V, Giordano S, Lanza K, Negron N, Ni M, Wei Y, Atwal GS, Murphy AJ, Stahl N, Yancopoulos GD, Kyratsous CA (August 2020). “Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies”. Science 369 (6506): 1014–1018. Bibcode: 2020Sci...369.1014B. doi:10.1126/science.abd0831. PMC 7299283. PMID 32540904.
europa.eu
ema.europa.eu
- “EMA starts rolling review of REGN‑COV2 antibody combination (casirivimab / imdevimab)” (Press release). European Medicines Agency (EMA). 1 February 2021. 2021年2月1日閲覧. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- “EMA reviewing data on monoclonal antibody use for COVID-19” (Press release). European Medicines Agency (EMA). 4 February 2021. 2021年3月4日閲覧.
- “EMA issues advice on use of REGN-COV2 antibody combination (casirivimab / imdevimab)” (Press release). European Medicines Agency (EMA). 26 February 2021. 2021年3月5日閲覧. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
fda.gov
- “Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19”. U.S. Food and Drug Administration (FDA) (Press release). 21 November 2020. 2020年11月21日閲覧.
この記述には、アメリカ合衆国内でパブリックドメインとなっている記述を含む。 - “Fact Sheet For Health Care Providers Emergency Use Authorization (EUA) Of Casirivimab And Imdevimab” (PDF). U.S. Food and Drug Administration (FDA). 2021年7月1日閲覧。
harvard.edu
ui.adsabs.harvard.edu
- Baum A, Fulton BO, Wloga E, Copin R, Pascal KE, Russo V, Giordano S, Lanza K, Negron N, Ni M, Wei Y, Atwal GS, Murphy AJ, Stahl N, Yancopoulos GD, Kyratsous CA (August 2020). “Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies”. Science 369 (6506): 1014–1018. Bibcode: 2020Sci...369.1014B. doi:10.1126/science.abd0831. PMC 7299283. PMID 32540904.
indiatimes.com
timesofindia.indiatimes.com
- “India approves Roche/Regeneron antibody cocktail to treat Covid-19 - India News”. The Times of India (2021年5月5日). 2021年6月8日閲覧。
nih.gov
dailymed.nlm.nih.gov
- “Casirivimab injection, solution, concentrate Imdevimab injection, solution, concentrate REGEN-COV- casirivimab and imdevimab kit”. DailyMed. 2021年3月18日閲覧。
ncbi.nlm.nih.gov
- Baum A, Fulton BO, Wloga E, Copin R, Pascal KE, Russo V, Giordano S, Lanza K, Negron N, Ni M, Wei Y, Atwal GS, Murphy AJ, Stahl N, Yancopoulos GD, Kyratsous CA (August 2020). “Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies”. Science 369 (6506): 1014–1018. Bibcode: 2020Sci...369.1014B. doi:10.1126/science.abd0831. PMC 7299283. PMID 32540904.
pmc.ncbi.nlm.nih.gov
- Baum A, Fulton BO, Wloga E, Copin R, Pascal KE, Russo V, Giordano S, Lanza K, Negron N, Ni M, Wei Y, Atwal GS, Murphy AJ, Stahl N, Yancopoulos GD, Kyratsous CA (August 2020). “Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies”. Science 369 (6506): 1014–1018. Bibcode: 2020Sci...369.1014B. doi:10.1126/science.abd0831. PMC 7299283. PMID 32540904.
pubmed.ncbi.nlm.nih.gov
- Baum A, Fulton BO, Wloga E, Copin R, Pascal KE, Russo V, Giordano S, Lanza K, Negron N, Ni M, Wei Y, Atwal GS, Murphy AJ, Stahl N, Yancopoulos GD, Kyratsous CA (August 2020). “Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies”. Science 369 (6506): 1014–1018. Bibcode: 2020Sci...369.1014B. doi:10.1126/science.abd0831. PMC 7299283. PMID 32540904.
nytimes.com
- Thomas, Katie (2020年10月2日). “President Trump Received Experimental Antibody Treatment”. The New York Times. ISSN 0362-4331 2020年10月2日閲覧。
precisionvaccinations.com
- Hackett DW (2020年10月3日). “8-Gram Dose of COVID-19 Antibody Cocktail Provided to President Trump”. www.precisionvaccinations.com. オリジナルの2020年10月3日時点におけるアーカイブ。
prnewswire.com
- “Regeneron Reports Positive Interim Data with REGEN-COV Antibody Cocktail used as Passive Vaccine to Prevent COVID-19” (Press release). Regeneron Pharmaceuticals. 26 January 2021. PR Newswireより2021年3月19日閲覧.
recoverytrial.net
- “RECOVERY COVID-19 phase 3 trial to evaluate Regeneron's REGN-COV2 investigational antibody cocktail in the UK”. Recovery Trial. 2020年9月14日閲覧。
regeneron.com
- “Regeneron's COVID-19 Response Efforts”. Regeneron Pharmaceuticals. 2020年9月14日閲覧。
- “Casirivimab and Imdevimab”. Regeneron Pharmaceuticals. 2021年3月19日閲覧。
reuters.com
- Kelland, Kate (2020年9月14日). “Regeneron's antibody drug added to UK Recovery trial of COVID treatments”. Reuters 2020年9月14日閲覧。
streetinsider.com
- “Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81%”. streetinsider.com. 2021年4月12日時点のオリジナルよりアーカイブ。2021年4月12日閲覧。
toyokeizai.net
- “中外製薬ロナプリーブ｢コロナ第4の薬｣の正体 | 新型コロナ、長期戦の混沌”. 東洋経済オンライン (2021年7月24日). 2021年9月27日閲覧。
web.archive.org
- Hackett DW (2020年10月3日). “8-Gram Dose of COVID-19 Antibody Cocktail Provided to President Trump”. www.precisionvaccinations.com. オリジナルの2020年10月3日時点におけるアーカイブ。
wikipedia.org
en.wikipedia.org
- “Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19”. U.S. Food and Drug Administration (FDA) (Press release). 21 November 2020. 2020年11月21日閲覧. この記述には、アメリカ合衆国内でパブリックドメインとなっている記述を含む。
- “Fact Sheet For Health Care Providers Emergency Use Authorization (EUA) Of Casirivimab And Imdevimab” (PDF). U.S. Food and Drug Administration (FDA). 2021年7月1日閲覧。
- “EMA starts rolling review of REGN‑COV2 antibody combination (casirivimab / imdevimab)” (Press release). European Medicines Agency (EMA). 1 February 2021. 2021年2月1日閲覧. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- “EMA reviewing data on monoclonal antibody use for COVID-19” (Press release). European Medicines Agency (EMA). 4 February 2021. 2021年3月4日閲覧.
- “EMA issues advice on use of REGN-COV2 antibody combination (casirivimab / imdevimab)” (Press release). European Medicines Agency (EMA). 26 February 2021. 2021年3月5日閲覧. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
worldcat.org
search.worldcat.org
- Thomas, Katie (2020年10月2日). “President Trump Received Experimental Antibody Treatment”. The New York Times. ISSN 0362-4331 2020年10月2日閲覧。